| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 21.7× | −1.7× | |
| Price / Book | 1.9× | 2.0× | |
| Price / Sales | 2.7× | 4.0× | |
| Price / Free cash flow | 18.6× | −1.6× | |
| EV / EBITDA | 15.6× | −1.2× | |
| Earnings yield | 4.6% | −14.6% | |
| Free cash flow yield | 5.4% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,247.15 | −0.79% | $1.17T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $253.96 | −0.63% | $612.02B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $283.80 | −0.57% | $501.51B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $406.74 | +1.32% | $365.09B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $143.95 | −1.37% | $355.15B | 19.7× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.22 | −0.27% | $277.89B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $164.11 | −0.79% | $254.52B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $679.25 | −1.56% | $251.15B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $425.01 | −1.73% | $229.77B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $153.16 | −1.94% | $189.91B | 22.8× | 37.5% | +32.0% |
